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Abstract 
BACKGROUND: Aluminium phosphide (ALP) or rice pill is a substance used in developing countries due to its 
low cost as pesticides. The availability of this substance has been lead to an increased rate of the use of this toxic 
inorganic compound for suicide. Complications are considered to be dose-related toxicity and hospitalisation time, 
varying from hemodynamic disorder, hypoglycemia, hyperglycemia, shock, cardiotoxicity, pulmonary and renal 
failures. The consumption of this substance is one of the major causes of mortality due to heart arrhythmia. QT 
dispersion represents a regional difference in ventricular repolarisation and electrical instability of the heart.  
AIM: The purpose of this study was to investigate the effect of ALP poisoning on QT dispersion. 
METHODS: In this study, 70 patients with ALP poisoning were enrolled, and 10 patients were excluded due to the 
exclusion criteria. QT dispersion rate was calculated in 60 patients using the standard electrocardiography at the 
time of referral. The above data were compared with the control group, which included 40 subjects with normal 
coronary angiography, and without cardiovascular risk factors. 
RESULTS: The findings presented herein indicated a significant correlation between QT dispersion and control 
group (P < 0.0.5). There was a significant relationship between the severity of acidosis and the patient's tablets –
taking a number (P < 0.05). However, there was no relationship between QT dispersion with the severity of 
acidosis and mortality in patients.  
CONCLUSION: Because there is no CAD risk factor in the population, it can be concluded that increase in QT 
dispersion in these individuals can be due to ALP poisoning; nevertheless, this is not considered to be a factor in 
increasing the morbidity of these patients. 
 
 
 
 
Introduction 
 
Aluminium phosphide (ALP) or rice tablet is a 
substance that is used in developing countries 
because of its cheapness as pesticides [1]. The 
availability of this substance has been led to an 
increased rate of the use of this toxic inorganic 
compound for suicide [2]. ALP poisoning is considered 
to be one of the major causes of suicidal deaths, and 
is sometimes accidental and rarely due to homicide 
[2], [3]. ALP poisoning has a high degree of mortality 
(30-100%), and the survival of patients is unlikely 
when swallowing more than 1.5 g of ALP [4].  
Toxicity with this substance is observed in 
both children and adults. ALP releases phosphine in 
the gastrointestinal tract, which is cytotoxic and 
releases free radicals and thus exerts its high toxicity 
[1]. These effects are not unique to a particular organ 
and are multisystemic [5], [6]. The effects of 
phosphine toxicity occur in a minute to 60 minutes 
after taking it. Phosphine causes cell hypoxia and 
small vessel damage, which ultimately leads to 
cardiotoxicity following anoxic myocardial damage and 
shock [7]. The cardiovascular effects of rice tablet 
include increased jugular venous pressure, S3, 
hypotension, shock, arrhythmia, myocarditis, and 
pericarditis [7]. As a matter of fact, the greatest toxic 
effect of ALP is myocardial suppression and severe 
cardiovascular collapse [8]. In various studies, 
myocardial damage and its effects on the 
electrocardiogram have been proven to be 
responsible for the mortality caused by ALP poisoning 
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[8]. Various studies have reported that 38-91% of 
patients have electrocardiogram changes as cardiac 
conduction defects, including RBBB, LBBB, 
atrioventricular block, and rarely sinus block. 
On the other hand, there is arrhythmia, 
including junctional rhythm, extra supraventricular 
systole and ventricular fibrillation (V-fib or VF). 
Eventually, reparative disorders such as ST-segment 
depression, ST-segment elevation, and T wave 
inversion occur following ALP poisoning [8]. 
Therefore, the patient should be monitored for cardiac 
arrhythmias immediately. 
QT dispersion was defined to be the 
difference between the maximum and minimum QT 
interval of the 12-standard lead of electrocardiography 
(ECG), which indicates ventricular repolarisation and 
electrical instability of the heart. If this difference is at 
a high level, the risk of arrhythmias can be increased 
(9). QT dispersion is a phenomenon described by 
Campell et al. They showed that there are small but 
consistent differences between the QT intervals of 
different leads. Evidence suggests that the degree of 
QT variability in a variety of leads can provide 
valuable clinical information demonstrating the 
underlying abnormalities, including ventricular 
repolarisation [9]. Previous studies have shown that 
QT dispersion changes during myocardial ischemic 
episodes. Recent studies indicate that QT dispersion 
reaches its highest level during the early hours of 
ischemia and decreases over time as a result of 
receiving thrombolysis treatments. It also increases in 
patients who develop ventricular fibrillation (VF). 
Ischemia at the microvascular level or autonomic 
changes at the heart rate may be the cause of this 
phenomenon. 
Changes in QT dispersion during myocardial 
infarction have been interesting but have not yet been 
clinically proven. Although they were already used in 
the area of the efficacy and safety of antiarrhythmic 
drugs [9]. The difference between the QT intervals of 
different leads and its measurement as a 'QT 
dispersion' can make challenging our current 
approach more likely to assess the risk of 
arrhythmias. QT dispersion provides a simple, 
inexpensive and non-invasive potential method of 
measuring the underlying dispersion of improved 
ventricular irritability. Continued development of QT 
dispersion can be linked to important clinical benefits, 
especially the benefits and risks of treatment with 
antiarrhythmic drugs [9]. 
Accordingly, this study was conducted to 
determine the effect of ALP on QT dispersion as a 
possible risk factor for sudden cardiac death, 
arrhythmias and a fatal change in ECG. Since this 
substance is one of the most important causes of 
mortality and morbidity of heart arrhythmia [10], the 
aim of this study was to investigate the cardiotoxicity 
effects of ALP on the cardiovascular system and 
particularly the QT dispersion in ALP poisoning. 
Material and Methods 
 
The medical records of 70 patients diagnosed 
with ALP poisoning were investigated in Emam Reza 
Hospital, Mashhad, Iran. ECG was evaluated at the 
time of admission, and their QT dispersion was 
calculated. Also, prognostic factors such as the 
number of hospital days, the need for a ventilator, the 
severity of acidosis, and the use of drugs such as 
magnesium sulfate and calcium gluconate were used. 
The control group consisted of 40 patients 
without a cardiovascular risk factor that had normal 
coronary angiography, 
Inclusion criteria: Patients with a definite 
diagnosis of ALP poisoning that did not have a history 
of heart disease.  
Exclusion criteria: Patients who have a branch 
block in the ECG and patients with a history of heart 
disease. 
 
Data analysis 
Data are presented using descriptive statistics 
like frequency and mean ± standard deviation. T-test 
and Mann-Whitney-U tests were applied to assess the 
relationship between qualitative and quantitative 
variables. Also, the Kruskal-Wallis test was used as a 
non-parametric method for testing groups, and the 
relationship between qualitative variables was 
determined using chi-square test. Statistical analysis 
was performed using SPSS version 22. A p-value of 
less than 5% was considered statistically significant. 
 
Ethical considerations 
A) The patient's secrets were completely 
preserved until the end of the study. 
B) In the case of intervention or diagnosis, common 
diagnostic and therapeutic methods along with 
success rate, complications and benefits of common 
and interventional methods were determined. 
 
 
Results 
 
In this study, out of 70 patients, 10 patients 
were excluded according to the exclusion criteria. 
Then, patients were compared with the control group. 
The average age of the patients was 25.55 ± 7.53 in 
the population. The lowest and highest age was 
determined as 12 and 45 years, respectively. Of the 
60 patients, 27 (45%) were female, and 33 (55%) 
were male. The distribution of smokers and non-
smokers showed that 30% of patients were smokers. 
In the present study, blood pressure, hyperlipidemia 
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and diabetes were also investigated. Among all 60 
patients enrolled in the study, only one person was 
found to suffer from hypertension, and no diabetic or 
hyperlipidemic patients were diagnosed (Table 1). 
Table 1: Basic characteristics of patients with aluminium 
phosphide poisoning 
 Number of patients with poisoning with aluminium phosphide: 60 
patients 
 Number Per cent Mean ± SD 
Age   25.55 ± 7.53 
Female 27 45%  
Male 33 55%  
Cigarette 18 30%  
Blood pressure 1 1.7%  
Diabetes _ _  
Hyperlipidemia _ _  
 
Table 2 shows the frequency of QT dispersion 
changes in the population under study, with an 
average QT dispersion of 60.66 ± 22.08.  
Table 2: Frequency QT dispersion changes in patients with 
ALP poisoning 
QT dispersion (ms) Number Percent 
04 30 50% 
04 2 3.33% 
04 25 41% 
044 2 3.33% 
024 1 1.6% 
 
Based on T-test, there is a significant 
relationship between patient group and control group, 
with QT dispersion was increased in the patients' 
group (P = 0.027), (Table 3). 
Table 3: Comparison of QT dispersion values between the 
control group and the patient's group 
QT dispersion values  Number Mean Standard deviation 
Group case 60 60.66 22.08 
Group control 40 39.25 19.26 
 
Comparison of two variables such as age, 
number of hospital days, number of pills, duration of 
hospitalisation, acidosis severity and QT dispersion 
was performed. The results demonstrated a significant 
relationship between the number of taking the pills 
and the severity of acidosis. The increase in the 
number of pills consumed was highly linked to 
increased acidosis (P = 0.020), and no significant 
relationship was found between other variables such 
as acidosis and QT scattering. There was also a 
correlation between age and QT dispersion, where QT 
dispersion increased with age (P = 0.040; Table 4). 
Table 4: Correlation test for age variables, hospital admission 
time, acidosis severity, number of pills, duration of hospital 
visits in comparison with QT dispersion 
Comparison 
of QT 
dispersion 
value with 
patient age 
Comparison 
of QT 
dispersion 
value with 
acidosis 
severity 
Comparison 
of QT 
dispersion 
value with a 
duration of a 
hospital visit 
Comparison 
of QT 
dispersion 
value with the 
number of 
pills 
Comparison 
of QT 
dispersion 
value with 
hospital 
admission 
time 
 
0.040 0.902 0.692 0.236 0.293 P value  
 
Figure 1 shows the frequency distribution of 
hospital admission time in patients with ALP 
poisoning, demonstrating an average referral time of 
4.006 ± 3.22. 
 
Figure 1: Frequency distribution of hospital visit time in patients with 
ALP poisoning 
 
The frequency distribution of patients based 
on the number of pills consumed is shown in Figure 2 
that patients consumed an average of 1.09 ± 1.70 
pills. 
 
Figure 2: Distribution of patients in terms of the number of pills used 
 
In the current study, the patients' medical 
records were reviewed, and the type of treatment was 
recorded, were 4 treatment groups was found (Table 
5). 
Table 5: Frequency of patients with ALP poisoning based on 
the type of treatment received 
type of treatment received Number of patients per cent 
HCO3+MgSO4+CaGluconate (First therapeutic group) 24 40% 
HCO3+MgSO4 (Second Therapeutic Group) 12 20% 
HCO3 (Third Therapeutic Group) 20 33.33% 
Conservative Tx (Fourth Therapeutic Group) 4 6.66% 
 
The frequency of patients with ALP poisoning 
is indicated in Figure 4, based on the number of 
hospital admissions days, and the average number of 
admission days was determined as 5.343 ± 3.08. 
Frequency of mortality in patients with ALP 
poisoning by sex revealed that 8 of the patients who 
died were female and 10 were male, as well as 19 of 
the surviving patients were female, and 23 were male. 
Based on the Chi-Square test, mortality of patients 
with ALP poisoning was not related to their sex (P = 
0.955). The findings revealed that 33.3% (20 patients) 
of the patients needed intubation, and the remaining 
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did not require intubation. Of the 18 dead patients, 5 
were smokers. Among 42 survivors, 13 patients were 
found to be smokers. Chi-Square test indicated no 
significant relationship between the mortality rate of 
the patients and their smoking (P = 0.806). 
 
Figure 3: Frequency of patients with ALP poisoning by type of 
treatment and sex 
 
The Mann-Whitney test revealed that there 
was no significant correlation between QT dispersion 
and mortality in patients with ALP (P-value = 0.471). 
 
Figure 4: Frequency of patients with ALP poisoning based on the 
number of hospital admissions days 
 
According to the T-test, a significant 
correlation was found between the mortality of the 
patients and the severity of acidosis (P = 0.000). 
Based on the Chi-Square and Cross tab tests, 
out of the 20 cases underwent intubation, 18 of them 
finally died. In other words, all died patients were 
under intubation. Also, a direct linear correlation was 
found between the patients who died and the patients 
with intubation (P = 0.000). Additionally, no significant 
correlation was determined between the mortality rate 
and the type of treatment (P-value: 0.232). 
 
Figure 5: Frequency of mortality in patients with ALP poisoning 
based on the type of treatment 
Mann-Whitney test exhibited that there is a 
significant relationship between mortality rate and 
several pills used (P = 0.018), as well as between 
mortality rate and several hospital days (P = 0.004). 
Based on the findings presented herein, no 
relationship was observed between mortality and the 
age of the patients and the duration of the visit. 
 
 
Discussion 
 
ALP poisoning has a high toxic effect, where 
its complications are dose-dependent and hospital-
based, and vary from hemodynamic disorder, 
hypoglycemia, hyperglycemia, shock, cardiotoxicity, 
pulmonary and renal failures [10], [11], [12], [13].  
Direct toxic damage of ALP on the 
myocardium causes cardiac arrhythmias [14]. 
Hypotension and shock occur 3 to 6 hours after taking 
ALP. In patients who survive, cardiotoxicity and 
hypoxia can be disappeared after 5 to 7 days 
following phosphorus excretion and the return of 
normal cell metabolism. This toxic injury causes a 
variety of lethal changes in the ECG 6 to 24 hours 
after taking ALP in patients who have died, and non-
lethal changes appear in patients who survive, within 
the first 12 to 24 hours of use, and also disappear 56 
to 80 hours later. Death following the use of a rice pill 
in the first 24 hours is cardiogenic due to ECG 
abnormalities and shock [7]. In a study by Lall et al., 
(1997), it was reported that ECG changes were found 
at all dose in rats, including initial tachycardia and ST-
segment elevation progressing to QRS broadening. 
The cause of cardiotoxicity of ALP, in addition to 
reducing cellular metabolism of the myocardium, is 
due to necrosis of the cardiac tissue following the 
release of reactive oxygen intermediates [15]. 
In a study by Katira et al., (2005), 90 patients 
with ALP poisoning were studied over 3 years. 
According to this study, death was due to poison-
induced toxic chemical myocarditis, which was 
accompanied by electrocardiographic changes [16]. In 
the study of Chugh and colleagues, arrhythmias, it 
has been revealed that conduction disturbances and 
ischaemic pattern were observed in the same 
frequency. ECG abnormalities, including varied sino-
atrial blocks, early repolarisation syndrome 
bradycardia-tachycardia syndrome that has not been 
reported before, were seen in this study. Clinical 
profile of patients was the same regardless of the 
existence or absence of ECG changes. According to 
the aforementioned study, ECG abnormalities do not 
affect motility. Hypoxemia and shock, as well as 
severity of poisoning, dose of poison consumed, were 
not known to cause these abnormalities [17]. 
According to these studies, several ECG 
changes have been discussed, but QT dispersion 
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changes have not yet been evaluated. Therefore, the 
current study was aimed to determine the effect of 
aluminium phosphide on QT dispersion as a possible 
risk factor for sudden cardiac death and arrhythmias 
and a deadly change in ECG. In the study, 70 patients 
with aluminium phosphide poisoning were enrolled, 
and the QT dispersion rate was calculated in 60 
patients using a standard electrography that was 
taken at the time of referral. Furthermore, the data 
were compared with the control group in which 40 
subjects included without cardiovascular risk factors, 
with normal coronary angiogram. 
Regarding the findings, the prevalence of ALP 
poisoning in the young population of Iran was higher. 
Also, the prevalence of ALP poisoning in the study 
population was higher in males than females. The 
mean QT dispersion in the studied population and the 
control group was calculated as 60.66 ± 22.08 and 
39.25 ± 19.26, respectively. There was a significant 
correlation between QT dispersion as a comparison of 
both group (P = 0.027), and the QT dispersion rate 
was found to be higher in the patient's group when 
compared with the control group. The findings 
revealed no significant correlation between mortality 
rate of patients with QT dispersion rate. Also, no 
significant relationship was found between the 
mortality rate of patients with the type of treatment 
received. QT dispersion did not correlate with the 
severity of acidosis in patients. However, there was a 
significant correlation between QT dispersion rate and 
ageing (P = 0.040). 
On the other hand, a significant relationship 
was observed between the severity of acidosis and 
patient's tablets –taking the number (P = 0.02). 
Moreover, there was a significant relationship 
between the mortality of the patients and the severity 
of acidosis (P = 0.000), but there was no relationship 
between the severity of acidosis and the 
hospitalisation time. A significant correlation was also 
found between the mortality rate of patients and the 
taking numbers of pills and the number of hospital 
admissions days (P = 0.004), were taking larger 
numbers of pills was associated with the more 
mortality rate in patients (P = 0.018). Also, there was a 
significant relationship between patients in need of 
intubation and those who eventually died, as a matter 
of fact, most intubated patients died (P = 0.000). 
According to the patient records, the cause of 
mortality was the appearance of multiple organ failure 
symptoms, as well as cardiogenic shock, and 
arrhythmia. 
 In conclusion, given that there is no risk factor 
for CAD in the population studied, it can be concluded 
that increased QT dispersion in these individuals was 
due to ALP poisoning. But this is not a factor in 
increasing the morbidity of these patients. However, 
further studies are recommended in this area to 
assess the risk of arrhythmias following increased QT 
dispersion in these patients. 
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